Your browser doesn't support javascript.
loading
Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer.
Wang, Qiang; Zhou, Danting; Wu, Fang; Liang, Qingchun; He, Qiongzhi; Peng, Muyun; Yao, Tianyu; Hu, Yan; Qian, Banglun; Tang, Jingqun; Wang, Xiang; Liu, Wenliang; Yu, Fenglei; Chen, Chen.
Afiliación
  • Wang Q; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Zhou D; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Wu F; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Liang Q; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
  • He Q; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Peng M; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Yao T; Geneplus-Beijing Institute, Beijing, China.
  • Hu Y; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Qian B; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Tang J; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Wang X; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Liu W; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Yu F; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Chen C; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
Front Oncol ; 11: 680287, 2021.
Article en En | MEDLINE | ID: mdl-34395248

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza